欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5892/001
药品名称Glycopyrronium Xiromed 44 microgram, inhalatiepoeder in harde capsule
活性成分
    • Glycopyrronium bromide 44.0 µg
剂型Inhalation powder, hard capsule
上市许可持有人Medical Valley Invest AB Bradgardsvagen 28 2 Tr Skane Lan, Hollviken 236 32, Sweden
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
      Glycopyrronium "Medical Valley"
    • Sweden (SE)
    • Norway (NO)
许可日期2024/09/25
最近更新日期2025/02/12
药物ATC编码
    • R03BB06 glycopyrronium bromide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase